These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 29503645)

  • 1. Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?
    Christen U; Hintermann E
    Front Immunol; 2018; 9():163. PubMed ID: 29503645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
    Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
    J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
    Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
    J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
    Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
    Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
    Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
    J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models for autoimmune hepatitis.
    Christen U; Holdener M; Hintermann E
    Autoimmun Rev; 2007 Apr; 6(5):306-11. PubMed ID: 17412303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6.
    Komurasaki R; Imaoka S; Tada N; Okada K; Nishiguchi S; Funae Y
    Drug Metab Pharmacokinet; 2010; 25(1):84-92. PubMed ID: 20208391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoimmune hepatitis and overlap syndrome: diagnosis].
    Berg PA; Klein R
    Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model.
    Müller P; Messmer M; Bayer M; Pfeilschifter JM; Hintermann E; Christen U
    J Autoimmun; 2016 May; 69():51-8. PubMed ID: 26924542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
    Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
    Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 2D6 as a model antigen.
    Christen U; Holdener M; Hintermann E
    Dig Dis; 2010; 28(1):80-5. PubMed ID: 20460894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new epitope of CYP2D6 recognized by liver kidney microsomal autoantibody from japanese patients with autoimmune hepatitis.
    Imaoka S; Obata N; Hiroi T; Osada-Oka M; Hara R; Nishiguchi S; Funae Y
    Biol Pharm Bull; 2005 Dec; 28(12):2240-3. PubMed ID: 16327157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
    PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.
    Sebode M; Weiler-Normann C; Liwinski T; Schramm C
    Front Immunol; 2018; 9():609. PubMed ID: 29636752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
    Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies and their antigens in autoimmune hepatitis.
    Bogdanos DP; Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.